Global Hyperbaric Oxygen Therapy Market

Hyperbaric Oxygen Therapy Market Size, Share, Growth Analysis, By Product(Monoplace oxygen chambers, multiplace oxygen chambers, topical oxygen chambers, portable oxygen chambers), By Application(Decompression sickness, wound healing, infectious diseases, gas embolism), By End user(Hospitals, Ambulatory care centers, outpatient clinics, standalone hyperbaric treatment centers), By Region - Industry Forecast 2025-2032


Report ID: SQSG35A2093 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 96 | Figures: 76

Hyperbaric Oxygen Therapy Market Insights

Hyperbaric Oxygen Therapy Market size was valued at USD 34.5 Billion in 2023 and is poised to grow from USD 36.75 Billion in 2024 to USD 57.62 Billion by 2032, growing at a CAGR of 6.51% during the forecast period (2025-2032).

The hyperbaric oxygen therapy device plays an important role in various medical issues as it is a medical device that is used to provide an optimum level of oxygen to the tissues in the human body under high atmospheric pressure.

The air pressure, in this medical treatment, is increased two to three times higher than the normal air pressure. Thus, the oxygen-carrying blood helps to fight bacteria and other unwanted hosts in the body by promoting healing.

This medical treatment is used to treat wounds as a result of radiation, air bubbles in blood vessels, and many other serious infections like diabetes.

The Food and Drug Administration (FDA) has approved 13 medical uses of hyperbaric oxygen therapy (HBOT) to date. The regulatory has approved a number of indications such as pulmonary embolism, severe anaemia, decompression sickness, burns and brain abscesses to name a few out of the thirteen approved indications.

Another factor that is projected to accelerate the growth of the market include the huge price tag associated with hyperbaric oxygen therapy (HBOT) products.

US Hyperbaric Oxygen Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Hyperbaric Oxygen Therapy Market size was valued at USD 34.5 Billion in 2023 and is poised to grow from USD 36.75 Billion in 2024 to USD 57.62 Billion by 2032, growing at a CAGR of 6.51% during the forecast period (2025-2032).

The global Hyperbaric Oxygen Therapy market is highly competitive with the presence of several international and local players across the globe. Product diversification, advancement, merger & acquisition and quality enhancement are the leading key strategies opting through prominent market players.  'Sechrist Industries, Inc.', 'OxyHeal International', 'ETC Hyperbaric Chambers', 'Fink Engineering Pty Ltd.', 'SOS Medical Group Ltd.', 'Gulf Coast Hyperbarics, Inc.', 'Hyperbaric SAC', 'Hearmec Co., Ltd.', 'IHC Hytech B.V.', 'Hyperbaric Technology (HyTech) Finland Oy', 'Haux-Life-Support GmbH', 'BaroFold, Inc.', 'Hyperbaric Medical Solutions (HMS)', 'Hearmec Co., Ltd.', 'Hyperbaric Consulting', 'Haux-Life-Support GmbH', 'Hyperbaric Technologies, Inc.', 'Perry Baromedical Corporation', 'Respirox Technologies Inc.'

The rise in demand for devices for hyperbaric oxygen therapy is due to the increasing number of diabetic patients worldwide. As a result, the market will have an upward tendency over time.

Growing adoption of wound healing, widespread availability of monoplace systems, rising demand for the convenience of handling, and reduced hospital gas supply requirements are the factors that are anticipated to accelerate the sales of monoplace HBOT devices. Monoplace HBOT devices can handle a large number of patients with various diseases and assist medical personnel in monitoring all of the patient's indications and symptoms. Increased penetration to provide portability and user-friendly operability will also help to propel the HBOT devices market forward.

Globally, North America was the leading segment and accounted for around 32% of the total revenue in 2016. The U.S. was the leading market in 2022 and is also anticipated to hold largest revenue share over the forecast period. According to the American Venous Forum, advanced venous diseases characterized by skin changes and leg ulceration affect over 2.5 million people annually in the U.S. The increasing prevalence of chronic & acute wounds and simultaneously growing treatment rate due to the presence of developed healthcare technology, growing healthcare expenditure, and huge disposable income are some of the factors that are expected to boost the market over the coming years.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Hyperbaric Oxygen Therapy Market

Report ID: SQSG35A2093

$5,300
BUY NOW GET FREE SAMPLE